DAVID H BROIDE, MB CHB
Osteopathic Medicine at Campus Pt, La Jolla, CA
License number
California A38964
Category
Osteopathic Medicine
Type
Allergy & Immunology
License number
California A38964
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
2
9350 Campus Point Dr, La Jolla, CA 92037
3365 Willard St, San Diego, CA 92122
3365 Willard St, San Diego, CA 92122
Phone
(858) 657-8322
(858) 534-2110 (Fax)
(858) 534-2110 (Fax)
Professional information
Dr. David H Broide, La Jolla CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine, Allergy & Immunology
Address:
UCSD
9350 Campus Point Dr STE 2B, La Jolla 92037
(858) 657-8322 (Phone)
9350 Campus Point Dr STE 2B, La Jolla 92037
(858) 657-8322 (Phone)
Certifications:
Allergy & Immunology, 1987, Internal Medicine, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University Of Cape Town, Faculty Of Health Sciences
Graduated: 1976
Groote Schuur Hospital
Graduated: 1978
Brigham Womens Hospital
Graduated: 1981
Brigham Womens Hospital Waltham
Graduated: 1982
Ucsd Med Center
Graduated: 1987
University Of Cape Town, Faculty Of Health Sciences
Graduated: 1976
Groote Schuur Hospital
Graduated: 1978
Brigham Womens Hospital
Graduated: 1981
Brigham Womens Hospital Waltham
Graduated: 1982
Ucsd Med Center
Graduated: 1987
David H Broide, La Jolla CA
Specialties:
Allergist
Address:
9350 Campus Point Dr, La Jolla, CA 92037
9500 Gilman Dr, La Jolla, CA 92093
9500 Gilman Dr, La Jolla, CA 92093
Compositions And Methods For Modulating An Immune Response
US Patent:
2003007, Apr 24, 2003
Filed:
Mar 15, 2002
Appl. No.:
10/099512
Inventors:
Eyal Raz - Del Mar CA, US
David Broide - San Diego CA, US
David Broide - San Diego CA, US
International Classification:
A61K048/00, A61K039/35
US Classification:
514/044000, 424/275100
Abstract:
The present invention provides methods of maintaining suppression of a Th2 immune response, and methods of maintaining an increase in a Th1 immune response in an individual. The methods generally involve administering to an individual an effective amount of a first dose of a composition comprising an immunomodulatory nucleic acid, and, after a suitable time, administering at least a second dose of a composition comprising an immunomodulatory nucleic acid.
Methods Of Treating Pulmonary Fibrotic Disorders
US Patent:
2004024, Dec 9, 2004
Filed:
Oct 29, 2003
Appl. No.:
10/697817
Inventors:
Eyal Raz - Del Mar CA, US
David Broide - San Diego CA, US
Kenji Takabayashi - San Diego CA, US
David Broide - San Diego CA, US
Kenji Takabayashi - San Diego CA, US
International Classification:
A61K048/00
US Classification:
514/044000
Abstract:
The present invention provides methods of treating airway remodeling, the methods generally involve administering an effective amount of a Toll-like receptor agonist to an individual suffering from airway remodeling. The present invention provides methods of treating pulmonary fibrosis, the methods generally involving administering an effective amount of a Toll-like receptor agonist to an individual in need thereof. The present invention further provides pharmaceutical compositions comprising a TLR agonist and a formulation suitable for delivery by inhalation.